3P Biopharmaceuticals enters into manufacturing agreement with the Swedish company Affibody

Published: 27th May 2019
The Arrangement Covers Process Transfer, Process Development and GMP Manufacture of Affibody's Candidate
Read more

Large-scale manufacturing process for Strangvac now secured

We are so glad to be part of such an exciting project with the Swedish company INTERVACC, who we are working with on manufacturing of Strangvac® including the large-scale production of the vaccine against equine strangles.
Read more

3P Biopharmaceuticals enters into a new manufacturing agreement with the Dutch Biotech Company Xenikos

Published: 13th May 2019
3P and Xenikos started their collaboration in 2015 and now, according to this new agreement, 3P is responsible for the process transfer and scale-up, cGMP production for clinical trials and process validation.
Read more

Expansion of analytical capacities by 3P Biopharmaceuticals

Published: 2nd February 2019
3P Biopharmaceuticals has recently increased its analytical capacities and capabilities.
Read more

3P Biopharmaceuticals successfully completes the expansion and improvement of its facilities

Published: 28th February 2019
3P Biopharmaceuticals has successfully completed the project for the expansion and improvement of its facilities in Noáin (Spain) that had been carried out over the past months. The investment exceeded the 5 million euros invested in this project in addition to the 8 million euros that 3P has invested since 2013.
Read more

Spanish Biotech Industry: 3P selected as one of the Main Success Stories

3P Biopharmaceuticals has been selected as one of the Main Success Stories in the Spanish biotech sector in the last 10 years.
Read more

“ambr15 for cell culture process optimization” Webinar 3P Biopharmaceuticals and Sartorius Stedim Biotech

Did you miss our webinar about our experience using ambr® 15 with CHO-S cell line for the production of monoclonal antibodies?
Read more

3P Biopharmaceuticals and Viscofan to collaborate in an innovate advanced therapy project

Published: 7th June 2018
Cardiomesh is the project in which 3P Biopharmaceuticals and Viscofan are collaborating to develop and manufacture an innovative cell therapy product.
Read more

3P Biopharmaceuticals incorporates a LIMS, a Laboratory Information Management Systems

Published: 5th May 2018
3P Biopharmaceuticals is incorporating a new Laboratory Information Management Systems (LIMS) from Abbott Informatics, a global leader provider of laboratory solutions. The implementation phase is currently in progress together with Abbott Informatics who are also ensuring the specific training required for the completion of each milestone.
Read more

Get in touch

Let’s discuss your biologics journey.

Discover more about our people, our passion, and how we can work together to improve lives.